Effects of vitamin E on endothelium-dependent coronary flow in hypercholesterolemic dogs

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 43-51

  Ribeiro Jorge, Paulo Afonso ^a   Osaki, Michiko Regina ^a   De Almeida, Eros ^a   Neto, Luíz Credídio ^a   Metze, Konradin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acetylcholine; Dog; Endothelium dependent coronary flow; Hypercholesterolemia; Sodium nitroprusside; Vitamin E

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; CHOLESTEROL; MALONALDEHYDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIET; DOG; HEART RATE; HYPERCHOLESTEROLEMIA; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030604019     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05892-3     Document Type: Article

References (45)

1. [1] Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander W, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046.
2. [2] Jayakody L, Senaratne M, Thomson A, Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 1987;60:251.
3. [3] Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol 1989;256:C591.
4. [4] Ambrose JA, Tannenbaun MA, Alexapoulos D, Hjemdahl-Monsen CE, Leavy J, Weis M, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56.
5. [5] Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ, Selwyn AP, Ganz P. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993;87(suppl V):V56-V66.
6. [6] Webster MWI, Chesebro JH. Smith HC, Frye RL, Holmes DR, Reeder GS, Bresnahan DR. Nishimura RA, Clements IP, Bardsley WT, Grill DE, Bailey KR, Fuster V. Myocardial infarction and coronary artery occlusion: a prospective 5-year angiographic study. J Am Coll Cardiol 1990;15:218A.
7. [7] Blankenhorn DH, Nessin SA, Johnson RL, SanMarco ME, Azen SP, Cashin-Henfill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 1987;23:3233.
8. [8] Brown BG, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatric VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289.
9. [9] The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994;344:1383-1389.
10. [10] Harrison DG, Armstring ML, Freiman PC. Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808.
11. [11] Osborne JA, Lento PH, Siegfried MR, Sthal GL, Fusman B, Lefer AM. Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest 1989;83:465.
12. [12] Ribeiro Jorge PA, Ozaki MR, Metze K. Effects of Simvastatin and Pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits. J Toxicol Exp Pathol 1994;46:465.
13. [13] Treasure CB, Klein JL, Weintraub Ws, Talley DJ, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1995;332:481.
14. [14] Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519.
15. [15] Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993;341:1496.
16. [16] Witztun JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785.
17. [17] Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoproteins that increase atherogenicity. N Engl J Med 1989;320:915.
18. [18] Henning B, Chow CK. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad Biol Med 1988;4:99.
19. [19] Mugge A, Elmell JH, Peterson TE, Hofmayer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 1991;69:1293.
20. [20] Carew TE, Schwenke DC, Steinberg D. An anti-atherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that anti-oxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks slowing down the progression of atherosclerosis in WHHL rabbits. Proc Natl Acad Sci USA 1987;84:7725.
21. [21] Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Oshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in the WHHL rabbit, an animal model for familiar hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928.
22. [22] Dieber-Rotheeneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991;32:1325.
23. [23] Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Coldits GA, Willet WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993;328:1450.
24. [24] Naito HK, David JA. Laboratory consideration: determination of cholesterol, triglycerides, phospholipids and others lipids in blood and tissues. In: Laboratory and Research Methods in Biology and Medicine: Lipid Research Methodology. New York: Alan R. Liss, Inc., 1981;1-76.
25. [25] Folch JM, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1956;226:497.
26. [26] Cassini AF, Ferrali M, Pompella A, Maellaro E, Comporti M. Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene-intoxicated mice. Am J Pathol 1986;123:520.
27. [27] SAS (Statistical Analysis System) SAS/TAT user's guide, version 6, Fourth Edition, volume 1, 1990.
28. [28] Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992;85:1927.
29. [29] Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Anggard EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arteriosclerosis Thromb 1994;14:494.
30. [30] Qiao Y, Yokoyama M, Kameyama K, Asano G. Effect of vitamin E on vascular integrity in cholesterol-fed guinea pigs. Arteriosclerosis Thromb 1993;13:1885.
31. [31] Gey KF, Puska, P. Plasma vitamin E is inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci 1989;570:268.
32. [32] Riemerman RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991;337:1.
33. [33] Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet CC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444.
34. [34] Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum J. Effect of dietary anti-oxidant combinations in humans. Arteriosclerosis Thromb 1993;13:590.
35. [35] Belcher JD, Balla J, Balla G, Jacobs DR, Gross M, Jacob HS, Vercellotti GM. Vitamin E, LDL and endothelium. Arteriosclerosis Thromb 1993;13:1779.
36. [36] Jessup W, Rankin SM, Whalley CV, Hoult JRS, Scott J, Leake DS. α-Tocopherol consumption during low density lipoprotein oxidation. Biochem J 1990;265:399.
37. [37] Barclay LR, Bailey AMH, Kong D. The anti-oxidant activity of α-tocopherol-bovine serum albumin complex in micellar and liposome autoxidations. J Biol Chem 1985;260:15809.
38. [38] Fukuzawa K, Takase S, Tsukatani H. The effect of concentration on the anti-oxidant effectiveness of α-tocopherol of lipid peroxidation induced by superoxide Free Radical. Arch Biochem Biophys 1985;240:117.
39. [39] Boogaerts MA, Van de Broeck J, Deckmin H, Roelant C, Vermylen J, Verwilghen R. Protective effects of vitamin E on immune triggered granulocyte mediated endothelial injury. Thromb Haemost 1984;51:89.
40. [40] Westrop KL, Miller RA, Wilson RB. Vitamin E in a rabbit model of endogenous hypercholesterolemia and atherosclerosis. Nut Rep Int 1982;25:83.
41. [41] Godfried SSL, Combs GF, Sarako JM, Dillinghan LA. Potentiation of atherosclerotic lesions on rabbits by a high dietary level of vitamin E. Br J Nutr 1989;61:607.
42. [42] Williams RJ, Motteran JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992;94:153.
43. [43] Kleinvel HA, Demacker PNM, Stalenhoef AFH. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis Thromb 1994;14:1386.
44. [44] Keaney JF Jr, Gaziano JM, Xu A. Low-dose α-tocopherol improves and high doses α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994;93:844.
45. [45] Gilligan DM, Sack Mn, Guetta V, Casino PR, Quyyumi AA, Rader Dj, Panza J, Canon III RO. Effect of anti-oxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol 1994;24:1611.